YDES Stock Summary and Trading Ideas (YD Bio Limited - | NASDAQ:YDES)

YD Bio Ltd is a biotechnology company focused on regulated diagnostics, life science clinical services and healthcare product commercialization. Its operations include DNA methylation-based oncology testing programs in the United States under an LDT framework with CLIA-certified and CAP-accredited laboratory partners. The Company also provides life science distribution and clinical trial supply chain services, including procurement, logistics coordination and compliance-focused support for clinical development programs. It maintains ocular health product commercialization operations in the United States and consumer healthcare distribution activities in Asia. The Company operates in the United States and Taiwan, with Taiwan generating maximum revenue.

YD Bio Limited - trades on the NASDAQ stock market under the symbol YDES.

As of November 5, 2026, YDES stock price climbed to $7.18 with 76,771 million shares trading.

YDES has a beta of 0.21, meaning it tends to be less sensitive to market movements. YDES has a correlation of 0.00 to the broad based SPY ETF.

YDES has a market cap of $508.57 million. This is considered a Small Cap stock.

YDES has underperformed the market in the last year with a return of -34.0%, while SPY returned +9.7%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in YDES shares. However, YDES has outperformed the market in the last 3 month and 2 week periods, returning +209.5% and +24.4%, while SPY returned -4.7% and -5.2%, respectively. This indicates YDES has been having a stronger performance recently.

YDES support price is $6.21 and resistance is $7.69 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that YDES shares will trade within this expected range on the day.